1-3 of 3
Richard L. Tower, II, MD, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dexrazoxane Does Not Negatively Impact Survival Outcomes in Children and Young Adults with Acute Myeloid Leukemia (AML)

Nathan J. Schloemer, MD, Molly M. Brickler, RN, MSN, CPNP-AC, Vanessa C. McFadden, MD PhD, Yumei Cao, PhD, Raymond G. Hoffmann, PhD, Joseph R. Block, MD, Richard L. Tower, II, MD MS, Michael J. Burke, MD
Journal: Blood
Blood (2015) 126 (23): 4886.
https://doi.org/10.1182/blood.V126.23.4886.4886
Published: 2015
Journal Articles

Targeted Screening in Pediatric and Young Adult Oncology Patients Identifies Transfusional Iron Overload

Nathan J. Schloemer, MD, Melissa A. Acquazzino, MD, Deb Schmidt, RN, MSN, APNP, Lynnette Anderson, RN, MSN, APNP, Richard L. Tower, II, MD MS, J. Paul Scott, MD
Journal: Blood
Blood (2015) 126 (23): 4499.
https://doi.org/10.1182/blood.V126.23.4499.4499
Published: 2015
Journal Articles

Genetic Susceptibility Loci and Risk of Infant Leukemia by Subtype and MLL status: A Children's Oncology Group Report

Julie A. Ross, PhD, Amy M. Linabery, PhD, Crystal Blommer, BS, Erica Langer, BS, Logan G. Spector, PhD, Joanne M. Hilden, MD, Nyla A. Heerema, PhD, Richard L. Tower, II, MD, MS, Stella M. Davies, MBBS, PhD
Journal: Blood
Blood (2011) 118 (21): 749.
https://doi.org/10.1182/blood.V118.21.749.749
Published: 2011